Copyright
©The Author(s) 2002.
World J Gastroenterol. Aug 15, 2002; 8(4): 679-685
Published online Aug 15, 2002. doi: 10.3748/wjg.v8.i4.679
Published online Aug 15, 2002. doi: 10.3748/wjg.v8.i4.679
Table 6 Decrease of 4 serum fibrotic markers > 30% after treatment in two groups
| Groups | Total number 3 | Decrease of markers > 30% | Decrease of 2 markers > 30% | Decrease of 1 marker > 30% |
| IFN-γ | 30 | 1 (3.33%) | 6 (20%) | 13 (43.33%) |
| SA-B | 30 | 9 (30%) | 7 (23.33%) | 7 (23.33%) |
- Citation: Liu P, Hu YY, Liu C, Zhu DY, Xue HM, Xu ZQ, Xu LM, Liu CH, Gu HT, Zhang ZQ. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2002; 8(4): 679-685
- URL: https://www.wjgnet.com/1007-9327/full/v8/i4/679.htm
- DOI: https://dx.doi.org/10.3748/wjg.v8.i4.679